Clinical trials
Observational Hyperopia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 5 |
| Democritus University of Thrace | 2 |
| Food and Drug Administration (FDA) | 2 |
| Advanced Vision Care | 1 |
| Data Yakka, Inc. | 1 |
| Gemini Eye Clinic | 1 |
| Gobiquity Mobile Health | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Johnson & Johnson Vision Care, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperopia | 28 |
| Myopia | 23 |
| Astigmatism | 15 |
| Refractive Errors | 9 |
| Cataract | 7 |
| Presbyopia | 4 |
| Amblyopia | 2 |
| Dry Eye Syndromes | 2 |
| Glaucoma | 2 |
| Pseudophakia | 2 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.